Dow AgroSciences awarded costs of $5.3 million in lawsuit
In a ruling on Sept. 28, 2012, in the U.S. District Court, Middle District of North Carolina, two affiliates of Dow AgroSciences received a $5.3 million award against Bayer Bioscience in a lawsuit over Bayer’s Bacillus thuringiensis biotechnology patents that were ultimately found in multiple legal proceedings to be unenforceable due to inequitable conduct.
Originally filed in 1995 by Plant Genetic Systems (PGS) – a subsidiary of Bayer Bioscience – the lawsuit claimed that insect resistant corn products from Mycogen Plant Sciences and Agrigenetics – now affiliates of Dow AgroSciences – had violated two PGS patents. Friday’s $5.3 million award reimburses attorneys’ fees and costs incurred by the Dow AgroSciences affiliates in defending against Bayer’s litigation.
“We are pleased with the ruling, which supports Dow AgroSciences and its affiliates providing important insect protection products to U.S. farmers,” said William Wales, Vice President and General Counsel for Dow AgroSciences.
- Irrigation Association to release online courses with Cal Poly
- Monsanto to invest $120 million in Argentina
- Ag markets ended Tuesday mostly lower
- Fat molecules influence function of key photosynthesis protein
- Monsanto honored for efforts in developing agriculture in Vietnam
- Corn stocks top 1.2 billion bushels
- U.S. GMO labeling foes triple spending in first half of this year
- Source shows half of GMO research is independent
- Activists fighting Golden Rice even more in 2014
- White House issues veto threat on bill to block WOTUS rule
- How much corn can the ethanol industry use?
- East-West Seed signs marketing collaboration with Monsanto